Volume 83, Issue 3 pp. 430-437
Free Access

Functionally active complement proteins C6 and C7 detected in C6- and C7-deficient individuals

R. WÜRZNER

Corresponding Author

R. WÜRZNER

Departments of Immunology, University of Göttingen, Germany

Reinhard Würzner, MD, MRC Molecular Im munopathology Unit, University of Cambridge, Hills Road, GB-Cambridge CB2 2QH, UK.Search for more papers by this author
A. ORREN

A. ORREN

Molecular Immunopathology, MRC Centre, Cambridge, UK

Search for more papers by this author
P. POTTER

P. POTTER

Clinical Science and Immunology, University of Cape Town, South Africa

Search for more papers by this author
B. P. MORGAN

B. P. MORGAN

Medical Biochemistry, University of Wales, Cardiff, UK

Search for more papers by this author
D. PONARD

D. PONARD

Centre Hospitalier Regional, University of Grenoble, France

Search for more papers by this author
P. SPÄTH

P. SPÄTH

Blood Transfusion Service, Swiss Red Cross, Berne, Switzerland

Search for more papers by this author
M. BRAI

M. BRAI

Immunology, University of Palermo, Italy

Search for more papers by this author
M. SCHULZE

M. SCHULZE

Departments of Immunology, University of Göttingen, Germany

Search for more papers by this author
L. HAPPE

L. HAPPE

Departments of Immunology, University of Göttingen, Germany

Search for more papers by this author
O. GÖTZE

O. GÖTZE

Departments of Immunology, University of Göttingen, Germany

Search for more papers by this author
First published: March 1991
Citations: 45

SUMMARY

Two sensitive sandwich ELISAs based on monoclonal antibodies directed to native C6 and C7 allowed the detection and quantitation of these complement proteins in 20 out of 37 serum samples from individuals who had previously been classified as deficient in these proteins as assessed by immunochemical and/or functional assays. Furthermore, serum from four C6-deficient and one combined C6-/C7-deficient individual showed an increase in the terminal complement complex (TCC) and a decrease in native C6 and C7 after complement activation as assayed by specific ELISAs. Despite their (incomplete) deficiencies, these individuals therefore possess functionally active terminal complement proteins with respect to their ability to generate the TCC. As these individuals have no history of a susceptibility to neisserial infections, even low concentrations of functionally active C6 and C7 may provide sufficient protection against those micro-organisms whose destruction requires TCC formation.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.